Bria-IMT + checkpoint inhibitor: Phase I/II survival results compared to benchmark trials in metastatic breast cancer.

Authors: Saranya Chumsri, Chaitali Singh Nangia, Minal A. Barve, Kendrith M. Rowland, Ralph V. Boccia, John George Knecht, Blaise Bayer, Marcela Salgado, William Williams, Charles L. Wiseman, Giuseppe Del Priore, Carmen Calfa

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.1096

Source: Full article

---

Abstract

1096